Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseскороОткрытый API экосистемы
Латиница
Русский
Статья

To evaluate the rate of hypothyroidism after 1 year in patients treated with a fixed dose of 131I

Rabbani SyedInstitute of Nuclear Medicine, andNagesh NagabushanInstitute of Nuclear Medicine, andT.O. OdetoyinboDept of Diabetes and Endocrinology, Royal Free and University College London Medical School, Middlesex Hospital, London, UKJeffrey W. StephensDept of Diabetes and Endocrinology, Royal Free and University College London Medical School, Middlesex Hospital, London, UKSteven J. HurelDept of Diabetes and Endocrinology, Royal Free and University College London Medical School, Middlesex Hospital, London, UKJamshed BomanjiInstitute of Nuclear Medicine, and
ABI

Аннотация

Aim: The aim of this study was to evaluate the rate of hypothyroidism in 134 patients at 1 year after treatment with single fixed therapeutic dose of 600 MBq of 131I. Method: We performed a retrospective analysis of data from 134 patients (29 male, 105 female and median age 54 years) treated for hyperthyroidism between 1999 and Dec 2002. At presentation 71 patients (53%) had Graves’ disease (GD), 51 (38%) multinodular goitre (MNG) and 12 (9%) had functioning nodules (FN), documented by clinical biochemical and scintigraphic evidence of thyrotoxicosis. Patients were given a fixed therapeutic dose of 131I (600 MBq). Thyroid status was monitored regularly until hypothyroidism occurred or until TFTs became stable for over 1 year. Results: The incidence of hypothyroidism was determined at 1 year after the administration of radioiodine therapy. Seventy-three patients (55%) became hypothyroid, 54 (40%) became euthyroid and 7 (5%) remained thyrotoxic requiring further 131I therapy. Conclusion: A single 600 MBq dose of 131I effectively cures hyperthyroidism in 95% of patients at 1 year.

Темы

Идентификаторы

Цитирования и источники

Цитирований: 0Использованных источников: 0
Показатели — AkademScholar · Скоро